Security Reports > Diffusion Pharma
Diffusion Pharma
Data Breaches, Cyber Attacks and Security Report
https://diffusionpharma.com ᛫
Last updated May 26, 2020
https://diffusionpharma.com ᛫
Last updated May 26, 2020
UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more likely Diffusion Pharma is implementing good security practices.
Diffusion Pharmaceuticals Inc (NASDAQ:DFFN) is a publicly traded biotechnology and drug development company based in Charlottesville, Virginia, U.S. It was co-founded in 2001 by American life sciences entrepreneur David Kalergis and University of Virginia Chemical Engineering Professor John L. Gainer. Gainer is the inventor of the company’s platform technology of oxygen diffusion-enhancing compounds and its lead drug, trans sodium crocetinate (TSC).
This report shows a preliminary security rating for Diffusion Pharma. UpGuard scans billions of digital assets daily, in depth, across thousands of vectors. Data leak detection, vulnerability scanning and identity breach detection are just some of the advanced capabilities offered by the UpGuard platform.
Get a deeper scan →Read more about the latest issues in cybersecurity
Compare Diffusion Pharma's security performance with other companies